Telehealth · on the rundown Monday, March 9, 2026
Hims & Hers shares jump on Novo Nordisk GLP-1 deal
Covered by 2 outlets over 1 hour. All of them ran the same syndicated report. First reported by fool.com at 22:25 UTC on March 9, 2026.
- outlets2
- distinct reports1
- first to latest report1 h
- names in it2
What happened?
- Hims & Hers Health closed Monday at $22.15, up 40.72%, according to a report.
A machine summary written from the reports listed below; read them for the full account. How summaries are made and what is checked.
Who reported it, and when?
| Time | Report | Run by |
|---|---|---|
| Mar 9 22:25 | Stock Market Today, March 9: Hims & Hers Health Soars on Novo Nordisk Weight-Loss Drug Deal |
Who was named?
More news naming Novo Nordisk
- Sep 22 · Biotech GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk 4
- Sep 9 · Biotech Study links semaglutide to fewer asthma attacks, COPD flare-ups 2
- Sep 1 · Healthcare channelnewsasia.com: “Oncology firm Novocure says cyberattack exposed US patient records” 2
- Aug 26 · Cyber Boston Scientific says cybersecurity incident disrupted global order processing, shipping 4
- Aug 3 · Healthcare 933thedrive.com: “Eli Lilly to offer early access to next - gen obesity drug to some patients” 2
- Jul 21 · Legal Novo Nordisk sues Eli Lilly over alleged false advertising 5
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).